Barclays’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$362K Buy
47,888
+12,503
+35% +$94.5K ﹤0.01% 3205
2025
Q1
$196K Sell
35,385
-10,123
-22% -$56.1K ﹤0.01% 3340
2024
Q4
$262K Buy
45,508
+18,070
+66% +$104K ﹤0.01% 3392
2024
Q3
$285K Buy
27,438
+20,478
+294% +$213K ﹤0.01% 3310
2024
Q2
$90K Sell
6,960
-7,160
-51% -$92.6K ﹤0.01% 3421
2024
Q1
$246K Sell
14,120
-27,180
-66% -$474K ﹤0.01% 3228
2023
Q4
$388K Buy
41,300
+24,081
+140% +$226K ﹤0.01% 3142
2023
Q3
$193K Sell
17,219
-33,685
-66% -$378K ﹤0.01% 3052
2023
Q2
$1.09M Buy
50,904
+24,654
+94% +$527K ﹤0.01% 2096
2023
Q1
$1.06M Sell
26,250
-24,649
-48% -$997K ﹤0.01% 2094
2022
Q4
$2.37M Buy
50,899
+5,531
+12% +$257K ﹤0.01% 1537
2022
Q3
$2.35M Buy
45,368
+39,571
+683% +$2.05M ﹤0.01% 1547
2022
Q2
$274K Sell
5,797
-9,173
-61% -$434K ﹤0.01% 2960
2022
Q1
$1.07M Sell
14,970
-10,068
-40% -$717K ﹤0.01% 2251
2021
Q4
$1.87M Buy
25,038
+2,281
+10% +$171K ﹤0.01% 1848
2021
Q3
$1.29M Buy
22,757
+11,547
+103% +$656K ﹤0.01% 2110
2021
Q2
$495K Sell
11,210
-12,327
-52% -$544K ﹤0.01% 2476
2021
Q1
$1.16M Sell
23,537
-1,233
-5% -$60.8K ﹤0.01% 2219
2020
Q4
$1.04M Sell
24,770
-1,461
-6% -$61.6K ﹤0.01% 1951
2020
Q3
$1.2M Buy
26,231
+8,255
+46% +$378K ﹤0.01% 1809
2020
Q2
$904K Buy
17,976
+3,211
+22% +$161K ﹤0.01% 1986
2020
Q1
$759K Sell
14,765
-33,605
-69% -$1.73M ﹤0.01% 1903
2019
Q4
$2.99M Buy
48,370
+12,115
+33% +$748K ﹤0.01% 1601
2019
Q3
$2.18M Sell
36,255
-385
-1% -$23.1K ﹤0.01% 1689
2019
Q2
$3.09M Sell
36,640
-19,584
-35% -$1.65M ﹤0.01% 1449
2019
Q1
$5.37M Buy
56,224
+44,990
+400% +$4.3M ﹤0.01% 955
2018
Q4
$795K Sell
11,234
-17,299
-61% -$1.22M ﹤0.01% 1966
2018
Q3
$2.44M Buy
28,533
+23,078
+423% +$1.97M ﹤0.01% 1621
2018
Q2
$632K Sell
5,455
-2,642
-33% -$306K ﹤0.01% 2136
2018
Q1
$654K Sell
8,097
-18,863
-70% -$1.52M ﹤0.01% 2096
2017
Q4
$1.58M Buy
26,960
+325
+1% +$19.1K ﹤0.01% 1384
2017
Q3
$1.25M Sell
26,635
-3,325
-11% -$156K ﹤0.01% 1462
2017
Q2
$1.08M Sell
29,960
-29,304
-49% -$1.05M ﹤0.01% 1525
2017
Q1
$1.82M Buy
59,264
+48,370
+444% +$1.49M ﹤0.01% 1250
2016
Q4
$365K Buy
10,894
+10,096
+1,265% +$338K ﹤0.01% 1996
2016
Q3
$21K Buy
798
+423
+113% +$11.1K ﹤0.01% 3020
2016
Q2
$9K Sell
375
-1,869
-83% -$44.9K ﹤0.01% 3011
2016
Q1
$65K Buy
2,244
+1,862
+487% +$53.9K ﹤0.01% 2452
2015
Q4
$13K Sell
382
-4,543
-92% -$155K ﹤0.01% 2770
2015
Q3
$177K Buy
4,925
+4,557
+1,238% +$164K ﹤0.01% 2165
2015
Q2
$17K Sell
368
-371
-50% -$17.1K ﹤0.01% 3044
2015
Q1
$22K Sell
739
-93
-11% -$2.77K ﹤0.01% 3068
2014
Q4
$43K Sell
832
-37,516
-98% -$1.94M ﹤0.01% 3092
2014
Q3
$1.5M Sell
38,348
-30,540
-44% -$1.19M ﹤0.01% 1498
2014
Q2
$2.96M Sell
68,888
-11,571
-14% -$498K ﹤0.01% 1192
2014
Q1
$3.14M Sell
80,459
-72,584
-47% -$2.83M ﹤0.01% 1136
2013
Q4
$4.13M Sell
153,043
-54,234
-26% -$1.46M ﹤0.01% 1073
2013
Q3
$4.56M Buy
207,277
+27,708
+15% +$610K 0.01% 916
2013
Q2
$3.18M Buy
+179,569
New +$3.18M ﹤0.01% 1048